Golden
BrightGene

BrightGene

Biopharmaceutical company in research and development and manufacturing of medicines. BrightGene manufactures active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).

All edits

Edits on 15 Feb 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 15 Feb 2020 4:05 pm
Edits made to:
Article (+8/-8 characters)

Article

The company has a pipeline of generic drugs with molecules like EribulinEribulin, Trabectedin, Fondaparinux, Caspofungin and non-biological macromolecules such as Ferumoxytol and Ferric pyrophosphate citrate, also we have developed ADC cytotoxic payloads, like Maytansinoids, Auristatins, and Calicheamicin. BrightGene has cGMP compliance factories and has received approval from USFDA, EU, PMDA, KFDA and CFDA.

Edits on 15 Feb 2020
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 15 Feb 2020 1:18 am
Edits made to:
Article (+12/-12 characters)

Article

The company has a pipeline of generic drugs with molecules like Eribulin, Trabectedin, FondaparinuxFondaparinux, Caspofungin and non-biological macromolecules such as Ferumoxytol and Ferric pyrophosphate citrate, also we have developed ADC cytotoxic payloads, like Maytansinoids, Auristatins, and Calicheamicin. BrightGene has cGMP compliance factories and has received approval from USFDA, EU, PMDA, KFDA and CFDA.

Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 14 Feb 2020 4:51 pm
Edits made to:
Article (+11/-11 characters)

Article

The company has a pipeline of generic drugs with molecules like Eribulin, Trabectedin, Fondaparinux, CaspofunginCaspofungin and non-biological macromolecules such as Ferumoxytol and Ferric pyrophosphate citrate, also we have developed ADC cytotoxic payloads, like Maytansinoids, Auristatins, and Calicheamicin. BrightGene has cGMP compliance factories and has received approval from USFDA, EU, PMDA, KFDA and CFDA.

Edits on 14 Feb 2020
Meredith Hanel
Meredith Hanel edited on 14 Feb 2020 3:29 am
Edits made to:
Infobox (+1 properties)

Infobox

Location
Meredith Hanel
Meredith Hanel edited on 14 Feb 2020 3:18 am
Edits made to:
Infobox (+2 properties)
Description (+184 characters)
Article (+1502 characters)
Topic thumbnail

BrightGene

Biopharmaceutical company in research and development and manufacturing of medicines. BrightGene manufactures active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).

Article

BrightGene Bio-Medical Technology is a biopharmaceutical company in research and development as well as manufacturing of medicines. BrightGene manufactures active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) with a focus on the regulated market. BrightGene works on immune-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis.

The company has a pipeline of generic drugs with molecules like Eribulin, Trabectedin, Fondaparinux, Caspofungin and non-biological macromolecules such as Ferumoxytol and Ferric pyrophosphate citrate, also we have developed ADC cytotoxic payloads, like Maytansinoids, Auristatins, and Calicheamicin. BrightGene has cGMP compliance factories and has received approval from USFDA, EU, PMDA, KFDA and CFDA.

...

BrightGene manufactured the active pharmaceutical ingredients (APIs) of a remdesivir (GS-5734) imitation product. Remdesivir is the antiviral candidate from Gilead Sciences for treatment of infections with SARS-CoV-2 (2019-nCoV) that cause COVID-19 (coronavirus disease). Marketing of the imitation product was said to need authorization from Gilead. It is not known if any efforts were made by BrightGene to pursue authorization from Gilead. BrightGene stated that the product, if approved for marketing, will be supplied mainly through donations during the epidemic.

Infobox

Edits on 23 Oct 2019
Golden AI
Golden AI edited on 23 Oct 2019 12:01 pm
Edits made to:
Infobox (+1 properties)
Edits on 23 Oct 2019
Neelam Jhaveri
Neelam Jhaveri edited on 23 Oct 2019 8:13 am
Edits made to:
Topic thumbnail

BrightGene

Biopharmaceutical company in research and development and manufacturing of medicines. BrightGene manufactures active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).

Edits on 29 Aug 2019
Neelam Jhaveri
Neelam Jhaveri edited on 29 Aug 2019 12:03 pm
Neelam Jhaveri"Initial topic creation"
Neelam Jhaveri created this topic on 29 Aug 2019 12:03 pm
Edits made to:
Topic thumbnail

 BrightGene

Biopharmaceutical company in research and development and manufacturing of medicines. BrightGene manufactures active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs).

No more activity to show.